These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3131962)

  • 1. Influence of the primary anticoagulant on the recovery of factor VIII.
    Rock G
    Vox Sang; 1988; 54(2):125-6. PubMed ID: 3131962
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
    de Wit HJ; Scheer G; Muradin J; van der Does JA
    Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of anticoagulant on the in vitro level and stability of factor VIII procoagulant activity.
    Cumming AM; Wensley RT; Power DM; Delamore IW
    Thromb Res; 1987 Apr; 46(2):391-5. PubMed ID: 3111005
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of plasma with high levels of ionised calcium in the production of model scale coagulation factor concentrates.
    Farrugia A; Douglas S; James J; Whyte G; Herrington R
    Thromb Haemost; 1990 Nov; 64(3):374-8. PubMed ID: 2128967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple plasma anticoagulant-exchange method to increase the recovery of factor VIII in therapeutic concentrates.
    Cumming AM; Wensley RT; Winkelman L; Lane RS
    Vox Sang; 1990; 58(4):264-9. PubMed ID: 2119086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved yields of factor VIII from heparinized plasma.
    Rock GA; Cruickshank WH; Tackaberry ES; Palmer DS
    Vox Sang; 1979; 36(5):294-300. PubMed ID: 462918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of factor VIII activity in cryoprecipitates prepared from ACD and CPD plasma.
    Shanberge JN; Gruhl MC; Ikemori R; Inoshita K; Chalos MK; Aster RH
    Transfusion; 1972; 12(4):251-8. PubMed ID: 5039460
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
    Wensley RT; Snape TJ
    Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant.
    Prowse C; Waterston YG; Dawes J; Farrugia A
    Vox Sang; 1987; 52(4):257-64. PubMed ID: 3114954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CITRATE TOXICITY AND THE USE OF ANTICOAGULANT ACID CITRATE DEXTROSE BLOOD FOR EXTRACORPOREAL CIRCULATION.
    JENNINGS ER; BELAND AJ; COPE JA; ELLESTAD MH; MONROE C; SHADLE OW
    Surg Gynecol Obstet; 1965 May; 120():997-1008. PubMed ID: 14269851
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of citrate anticoagulants on factor VIII levels in plasma.
    Rock G; Tittley P; Fuller V
    Transfusion; 1988; 28(3):248-52. PubMed ID: 3130694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of heparin and calcium chloride on assay, stability, and recovery of factor VIII.
    Morgenthaler JJ; Zuber T; Friedli H
    Vox Sang; 1985; 48(1):8-17. PubMed ID: 3918394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulant in plasmapheresis].
    Yamashita M; Shintani S; Wada M; Kano M; Shimoyama T
    Nihon Rinsho; 1991 Dec; 49 Suppl():572-5. PubMed ID: 1808319
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term comparisons of citrate and heparin as anticoagulants for hemodialysis.
    Wiegmann TB; MacDougall ML; Diederich DA
    Am J Kidney Dis; 1987 May; 9(5):430-5. PubMed ID: 3107378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions to the optimal use of human blood. VIII. Stability of blood coagulation factor VII during collection and storage of whole blood and plasma.
    Vermeer C; Soute BA; Ates G; Hellings JA; Brummelhuis HG
    Vox Sang; 1976; 31(1 SUPPL):55-67. PubMed ID: 12616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Citrated bovine plasma and anticoagulants in vitro (heparin and heparinoids)].
    QUIVY D
    C R Seances Soc Biol Fil; 1955 Feb; 149(3-4):321-3. PubMed ID: 13240926
    [No Abstract]   [Full Text] [Related]  

  • 19. The stability of factor VIII in heparinized plasma.
    Krachmalnicoff A; Thomas DP
    Thromb Haemost; 1983 Jun; 49(3):224-7. PubMed ID: 6410534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulative effect of DDAVP and heparin in increasing plasma factor VIII levels.
    Rock G; Palmer DS
    Vox Sang; 1981; 41(1):56-60. PubMed ID: 6798759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.